跳至主要内容
临床试验/NCT04740866
NCT04740866Unknown不适用

Prospective Randomized Trial of Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer

Cairo University2 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年8月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
100
试验地点
2
主要终点
Local Control

研究概览

简要总结

This is a prospective randomized clinical trial in high risk urothelial bladder cancer to compare adjuvant radiotherapy versus observation after radical cyctectomy. This is to clarify the benefit of adjuvant radiotherapy while limiting gastrointestinal toxicities for patients with pathological high-risk bladder cancer through assessing locoregional control (LRC).

详细描述

This is prospective randomized trial in high risk urothelial bladder cancer that includes 2 arms. The randomization will be done by permuted block method to 2 equal comparable groups. The total number of subjects will be 50 in each arm (Total=100 subjects).

This study include patients who may receive neoadjuvant chemotherapy [Gemcitabine+Cisplatin]) or not.

Arm (1) in this study (N=50) will received irradiation of both the bladder tumor bed and pelvic lymph nodes using IMRT technique. For Arm (2) (N=50) will undergo observation following radical cystectomy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient with muscle-invasive urothelial cancer, who received neoadjuvant chemotherapy followed by radical cystectomy and urinary diversion with negative safety margin and belongs to one or more of the categories:
  • ≥ 18 years old.
  • PT3 or PT4a tumors.
  • Grade 3 urothelial cancer.
  • Positive infiltration of the dissected pelvic lymph nodes.

排除标准

  • Residual tumors upon cystectomy.
  • Previous pelvic irradiation.
  • Non-urothelial bladder tumors.
  • WHO performance status above
  • Any psychological, familial, sociological or geographical condition that hamper compliance with the study and/ or follow up schedule.

结局指标

主要结局

Local Control

时间窗: Two year

2-year local-regional control rate

次要结局

  • Disease Free Survival(Two year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed s. Zaghloul

Professor

Cairo University

研究点 (2)

Loading locations...

相似试验